My NCBISign In

Display Settings:

Format

Send to:

Choose Destination

    Retrovirology. 2007 Nov 8;4:80.

    Optimal design and validation of antiviral siRNA for targeting HIV-1.

    Naito Y, Nohtomi K, Onogi T, Uenishi R, Ui-Tei K, Saigo K, Takebe Y.

    Department of Biophysics and Biochemistry, Graduate School of Science, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan. y-naito@RNAi.jp

    We propose rational designing of antiviral short-interfering RNA (siRNA) targeting highly divergent HIV-1. In this study, conserved regions within HIV-1 genomes were identified through an exhaustive computational analysis, and the functionality of siRNAs targeting the highest possible conserved regions was validated. We present several promising antiviral siRNA candidates that effectively inhibited multiple subtypes of HIV-1 by targeting the best conserved regions in pandemic HIV-1 group M strains.

    PMID: 17996047 [PubMed - indexed for MEDLINE]

    PMCID: PMC2204037

    Supplemental Content

    Click here to read Click here to read
    Write to the Help Desk